SC8
6 minutes ago
And just pointing out the fact if MK fails to get Radiogel to market, it doesn't matter how great the product works. Likewise, even if first to market, with the pricing pressure to discourage competitive entry, what is the diminished buyout potential now that the tech is public domain?